ПИЛОН Эйприл Л. (US),БОРЖЕ Пьер Ф. Д. (CA),ФЛЕМО Луис Ф.Д. (CA)
申请号：
RU2012120671/15
公开号：
RU2012120671A
申请日:
2010.10.13
申请国别(地区):
RU
年份:
2013
代理人:
摘要：
1. The use of rhCC10 protein (human CC10 protein) for the preparation of a medicinal product for therapeutic or prophylactic effects on a viral infection. 2. The use according to claim 1, characterized in that the titer of the virus in the patient’s tissue is reduced. The use according to claim 1, characterized in that the viral infection is an influenza virus. The use according to claim 2, characterized in that the influenza virus is a type A.5 influenza virus. The use according to claim 2, characterized in that the influenza virus is a strain of H1N1 influenza virus. The use according to claim 1, characterized in that the tissue is a lung tissue. The use according to claim 1, characterized in that in a human or animal viral replication is suppressed at the cellular level. The use according to claim 1, characterized in that viral replication in infected cells is suppressed at the cellular level. The use according to any one of claims 1 to 8, characterized in that the rhCC10 protein acts on influenza infection, cures or prevents influenza infection. The use according to any one of claims 1 to 8, characterized in that the human CC10 protein (rhCC10 protein) is administered via the intranasal route. The use according to any one of claims 1 to 8, characterized in that the human CC10 protein (rhCC10 protein) is administered intravenously. The use according to any one of claims 1 to 8, characterized in that the human CC10 protein (rhCC10 protein) is administered with a combination of the intranasal and intravenous routes. The use of recombinant secretoglobin for the preparation of a medicinal product for the therapeutic or prophylactic effect on a viral infection. 14. The use of claim 13, wherein the titer of the virus in the patient’s tissue is reduced. Note1. Применение белка rhCC10 (человеческого белка СС10) для приготовления лекарственного средства для терапевтического или профилактического воздействия на вирусную инфекцию.2. Применение по п.1, отличающееся тем, что
